1. Home
  2. LCTX vs HFFG Comparison

LCTX vs HFFG Comparison

Compare LCTX & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.61

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

Logo HF Foods Group Inc.

HFFG

HF Foods Group Inc.

HOLD

Current Price

$2.11

Market Cap

113.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCTX
HFFG
Founded
1990
1997
Country
United States
United States
Employees
N/A
960
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Food Distributors
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
407.7M
113.0M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
LCTX
HFFG
Price
$1.61
$2.11
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
1.0M
197.2K
Earning Date
06-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,556,000.00
$1,201,667,000.00
Revenue This Year
$55.75
$4.36
Revenue Next Year
$2.96
$3.35
P/E Ratio
N/A
N/A
Revenue Growth
53.24
4.63
52 Week Low
$0.37
$1.38
52 Week High
$2.09
$4.93

Technical Indicators

Market Signals
Indicator
LCTX
HFFG
Relative Strength Index (RSI) 38.46 59.65
Support Level $1.55 $1.38
Resistance Level $1.84 $2.34
Average True Range (ATR) 0.10 0.16
MACD -0.04 0.02
Stochastic Oscillator 7.32 77.78

Price Performance

Historical Comparison
LCTX
HFFG

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

Share on Social Networks: